How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Pharma and Healthcare · Forecast 2027–2033
Imaging Diagnostic Catheters Market
- By Product Type: Intravascular Ultrasound (IVUS) Catheters, Optical Coherence Tomography (OCT) Catheters, Near-Infrared Spectroscopy (NIRS) Catheters, Pressure and Flow Measurement Catheters
- By Application: Cardiology, Peripheral Vascular, Neurovascular, Urology, Gastroenterology
- By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories
- By Technology: Rotational IVUS, Phased Array IVUS, Time-Domain OCT, Frequency-Domain OCT
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Projected to reach $X,XXX.XM by 2033 on sustained demand. Market Outlook →
- 03 Growth - X.XX% CAGR across 2027–2033, with the full year-by-year model inside. Market Outlook →
- 04 Leading segment - Intravascular Ultrasound (IVUS) Catheters leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 272 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.163 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.171 →
Full report · locked preview
Everything inside the Imaging Diagnostic Catheters Market report
A complete, evidence-based study - 11 chapters and 114 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 4
Application 5
End User 3
Technology 4
Companies profiled
Boston Scientific Corporation
Abbott Laboratories
Terumo Corporation
Siemens Healthineers
Philips Healthcare
Medtronic plc
Becton Dickinson and Company (BD)
Cook Medical
BIOTRONIK SE & Co. KG
Asahi Intecc Co. Ltd.
Cardiovascular Systems Inc.
Hansen Medical Inc.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Boston Scientific Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Abbott Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Siemens Healthineers
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Becton Dickinson and Company (BD)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Cook Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →BIOTRONIK SE & Co. KG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Asahi Intecc Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Cardiovascular Systems Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Hansen Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →St. Jude Medical (now part of Abbott)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Canon Medical Systems Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →GE Healthcare
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →
Global · 2025–2033
$1,622M by 2033 · 4.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Intravascular Ultrasound (IVUS) Catheters44.9
- Optical Coherence Tomography (OCT) Catheters10.0
- Near-Infrared Spectroscopy (NIRS) Catheters17.5
- Pressure and Flow Measurement Catheters27.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$369.4M → $482.5M · 3.4%
Europe$257.5M → $395.8M · 5.5%
Asia Pacific$235.1M → $334.6M · 4.5%
Latin America$145.5M → $236.3M · 6.2%
Middle East and Africa$112.0M → $172.7M · 5.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.702026
4.712027
4.712028
4.722029
4.742030
4.752031
4.772032
4.782033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Boston Scientific Corporation16.4
- Abbott Laboratories20.5
- Terumo Corporation10.4
- Siemens Healthineers10.7
- Philips Healthcare10.4
- Medtronic plc3.7
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type36.7%
Application25.3%
End User22.0%
Technology16.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America29.7
- Europe24.4
- Asia Pacific20.6
- Latin America14.6
- Middle East and Africa10.6
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Boston Scientific Corporation | 90 | 92 | 76 | 78 | 94 | 94 | 87 |
| Abbott Laboratories | 72 | 82 | 90 | 90 | 71 | 90 | 83 |
| Terumo Corporation | 65 | 85 | 88 | 65 | 68 | 83 | 76 |
| Siemens Healthineers | 58 | 78 | 60 | 70 | 68 | 82 | 69 |
| Philips Healthcare | 56 | 65 | 74 | 51 | 67 | 62 | 63 |
| Medtronic plc | 62 | 58 | 65 | 49 | 69 | 71 | 62 |
| Becton Dickinson and Company (BD) | 48 | 58 | 55 | 45 | 56 | 48 | 52 |
| Cook Medical | 42 | 59 | 59 | 41 | 43 | 35 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Boston Scientific Corporation
- Abbott Laboratories
- Terumo Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Boston Scientific Corporation | ✓ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Abbott Laboratories | ✓ | ◐ | ✓ | ✓ | ◐ | ✓ |
| Terumo Corporation | ◐ | ✓ | ✓ | − | ◐ | ✓ |
| Siemens Healthineers | ◐ | ✓ | − | ◐ | ✓ | ◐ |
| Philips Healthcare | ◐ | − | ✓ | ◐ | − | − |
| Medtronic plc | ◐ | ◐ | ◐ | − | ◐ | ◐ |
| Becton Dickinson and Company (BD) | ◐ | ◐ | − | − | ◐ | − |
| Cook Medical | − | − | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Boston Scientific Corporation87
2Abbott Laboratories83
3Terumo Corporation76
4Siemens Healthineers69
5Philips Healthcare63
6Medtronic plc62
7Becton Dickinson and Company (BD)52
8Cook Medical47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Boston Scientific CorporationAbbott Laboratories
Challenger2
Strong scale, closing on the leaders.
Terumo CorporationSiemens Healthineers
Contender2
Focused players with pockets of strength.
Philips HealthcareMedtronic plc
Niche2
Specialists in a single segment or region.
Becton Dickinson and Company (BD)Cook Medical
Go-to-market strategy
Land Product Type in North America, then scale across Imaging Diagnostic Catheters Market — a $649M beachhead inside a $10.7B market.
Beachhead (SOM)$649Mobtainable near-term
Serviceable (SAM)$3.64Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Intravascular Ultrasound (IVUS) Catheters
Best fit — highest urgency & budget in Product Type.
Economic buyer80 fit
Optical Coherence Tomography (OCT) Catheters
Strong fit — clear ROI and a fast path to value.
End user68 fit
Near-Infrared Spectroscopy (NIRS) Catheters
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel27%
Digital / self-serve18%
Marketplaces10%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Imaging Diagnostic Catheters Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified23%
Evaluation13%
Closed-won7%
$20.1KCAC
$69KLTV
3.5:1LTV : CAC
< 5 moCAC payback
Investment thesis
Imaging Diagnostic Catheters Market is a high-growth opportunity — $4.37B by 2033, compounding at 11.1%.
TAM · 2025$1.89Btoday
TAM · 2033$4.37Bforecast
CAGR11.1%2027–2033
Cumulative$26.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.37BTotal addressable market
SAM$1.67BServiceable available market
SOM$279MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.1% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.37BLarge & growingTAM by 2033 at 11.1% CAGR
$1.67BServiceable nowreachable with today’s model
$279MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.41BBear7.2% CAGR
$4.37BBase11.1% CAGR
$5.59BBull14.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Imaging Diagnostic Catheters Market — a $3.79B market by 2033. Plan: grow share from 9.3% to 18.5%.
Market size · 2033$3.79Btotal addressable
Market CAGR9.8%2027–2033
Target share18.5%from 9.3% today
Revenue ambition$701Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.3% | 18.5% | On track |
| Revenue | $344M | $701M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Ahead |
| Gross margin | 29.8% | 45.9% | At risk |
| Customer retention | 85.9% | 94.0% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $104M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeAhead
- Execution & talentAt risk
Sales deck · value proposition
Win the Imaging Diagnostic Catheters Market conversation — a $2.24B market you can size, segment and defend in minutes.
Market size · 2033$2.24Btotal opportunity
Growth9.7%CAGR to 2033
Addressable buyers1,620+accounts in scope
Typical ROI5.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.1×return on cost, year one
< 2 mopayback period
$43K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Boston Scientific CorporationAbbott LaboratoriesTerumo CorporationSiemens HealthineersPhilips HealthcareMedtronic plcBecton Dickinson and Company (BD)Cook Medical+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Imaging Diagnostic Catheters Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Imaging Diagnostic Catheters Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Pharma and Healthcare · scroll →Pulmonary Drug Delivery Devices Market
Market size, share, segmentation and regional forecast.
$12.3B by 2031 · 9.66% CAGR
View reportMedical Stapler Market
Market size, share, segmentation and regional forecast.
$11.3B by 2033 · 6.11% CAGR
View reportPDE Inhibitor Market
Market size, share, segmentation and regional forecast.
$5.9B by 2031 · 7.61% CAGR
View reportPhototherapy Equipments Market
Market size, share, segmentation and regional forecast.
$2.0B by 2032 · 4.07% CAGR
View reportPneumococcal Vaccines Market
Market size, share, segmentation and regional forecast.
$5.7B by 2033 · 9.14% CAGR
View reportOrthodontic Equipments Market
Market size, share, segmentation and regional forecast.
$8.1B by 2033 · 6.02% CAGR
View reportOrthopedic Trauma Device Market
Market size, share, segmentation and regional forecast.
$8.9B by 2031 · 3.27% CAGR
View reportOsteosynthesis External Fixation Devices Market
Market size, share, segmentation and regional forecast.
$4.1B by 2031 · 9.80% CAGR
View reportTreatment Patient Simulators Market
Market size, share, segmentation and regional forecast.
$5.8B by 2031 · 8.37% CAGR
View reportTangential Flow Filtration Device Market
Market size, share, segmentation and regional forecast.
$11.0B by 2031 · 9.61% CAGR
View reportTransfusion Diagnostic Equipments Market
Market size, share, segmentation and regional forecast.
$3.7B by 2033 · 5.77% CAGR
View reportPulmonary Arterial Hypertension Drugs Market
Market size, share, segmentation and regional forecast.
$3.6B by 2032 · 8.55% CAGR
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.